Risk assessment tools and adjuvant therapy for breast cancer

Author(s):
Noordhoek, I.
Published
2025
Publication type
Doctoral Thesis

Abstract

Breast cancer is the most common cancer in women. Several prognostic and predictive models have been developed to improve tailoring of adjuvant treatment to the individual patient. This thesis aimed to provide guidance in navigating different risk assessment tools. Once we are able to accurately assign to their risk group, we can optimize and personalize adjuvant treatment strategies.

Prognostic modelPredictive modelHormone receptor positive breast cancerExtended endocrine therapyBisphosphonate treatment
Defense date
2025-12-10
Language
English
Supervisor(s)
Portielje, J.E.A.; Liefers, G.J.
Advisor(s)
Kroep, J.R.
Committee member(s)
Linn, S.C.; Vrancken-Peeters, M.J.T.F.D.; Gelderblom, A.J.; Hage, J.A. van der; Wesseling, J.
Qualification
Ph.D.
Degree granting institution
Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University, Leiden
hdl
1887/4284751